The potential role of targeted therapies in the management of neuroendocrine tumours
- Author
- G Verset, I Borbath, T Delaunoit, P Demetter, G Demolin, A Hendlisz, Piet Pattyn (UGent) , S Pauwels, Marc Peeters (UGent) , G Roeyen, E Van Cutsem, P Van Hootegem, C Verslype and JL Van Laethem
- Organization
- Abstract
- The management of gastro-entero-pancreatic neuroendocrine tumours is evolving thanks to new TNM-classification, diagnostic and staging procedures and new therapeutic options. Targeting new pathways, mostly angiogenesis, development of novel agents is under way and opens new perspectives in controlling the evolution of these tumours and possibly changing their management. In parallel, new functional imaging techniques and biomolecular markers will be developed to provide adequate tools for the assessment of tumor response according to therapeutic intervention on angiogenesis, proliferation and apoptosis. This paper reviews the potential role of new investigational targeted agents which will likely become the backbone of future therapy of neuroendocrine tumors.
- Keywords
- targeted therapy, neuroendocrine tumours, ADVANCED CARCINOID-TUMORS, ENDOTHELIAL GROWTH-FACTOR, PHASE-II, DIGESTIVE-SYSTEM, EXPRESSION, OCTREOTIDE, COMBINATION, RECEPTORS, ALPHA, CELLS
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-687753
- MLA
- Verset, G., et al. “The Potential Role of Targeted Therapies in the Management of Neuroendocrine Tumours.” ACTA GASTRO-ENTEROLOGICA BELGICA, vol. 72, no. 1, 2009, pp. 59–62.
- APA
- Verset, G., Borbath, I., Delaunoit, T., Demetter, P., Demolin, G., Hendlisz, A., … Van Laethem, J. (2009). The potential role of targeted therapies in the management of neuroendocrine tumours. ACTA GASTRO-ENTEROLOGICA BELGICA, 72(1), 59–62.
- Chicago author-date
- Verset, G, I Borbath, T Delaunoit, P Demetter, G Demolin, A Hendlisz, Piet Pattyn, et al. 2009. “The Potential Role of Targeted Therapies in the Management of Neuroendocrine Tumours.” ACTA GASTRO-ENTEROLOGICA BELGICA 72 (1): 59–62.
- Chicago author-date (all authors)
- Verset, G, I Borbath, T Delaunoit, P Demetter, G Demolin, A Hendlisz, Piet Pattyn, S Pauwels, Marc Peeters, G Roeyen, E Van Cutsem, P Van Hootegem, C Verslype, and JL Van Laethem. 2009. “The Potential Role of Targeted Therapies in the Management of Neuroendocrine Tumours.” ACTA GASTRO-ENTEROLOGICA BELGICA 72 (1): 59–62.
- Vancouver
- 1.Verset G, Borbath I, Delaunoit T, Demetter P, Demolin G, Hendlisz A, et al. The potential role of targeted therapies in the management of neuroendocrine tumours. ACTA GASTRO-ENTEROLOGICA BELGICA. 2009;72(1):59–62.
- IEEE
- [1]G. Verset et al., “The potential role of targeted therapies in the management of neuroendocrine tumours,” ACTA GASTRO-ENTEROLOGICA BELGICA, vol. 72, no. 1, pp. 59–62, 2009.
@article{687753,
abstract = {{The management of gastro-entero-pancreatic neuroendocrine tumours is evolving thanks to new TNM-classification, diagnostic and staging procedures and new therapeutic options. Targeting new pathways, mostly angiogenesis, development of novel agents is under way and opens new perspectives in controlling the evolution of these tumours and possibly changing their management. In parallel, new functional imaging techniques and biomolecular markers will be developed to provide adequate tools for the assessment of tumor response according to therapeutic intervention on angiogenesis, proliferation and apoptosis.
This paper reviews the potential role of new investigational targeted agents which will likely become the backbone of future therapy of neuroendocrine tumors.}},
author = {{Verset, G and Borbath, I and Delaunoit, T and Demetter, P and Demolin, G and Hendlisz, A and Pattyn, Piet and Pauwels, S and Peeters, Marc and Roeyen, G and Van Cutsem, E and Van Hootegem, P and Verslype, C and Van Laethem, JL}},
issn = {{0001-5644}},
journal = {{ACTA GASTRO-ENTEROLOGICA BELGICA}},
keywords = {{targeted therapy,neuroendocrine tumours,ADVANCED CARCINOID-TUMORS,ENDOTHELIAL GROWTH-FACTOR,PHASE-II,DIGESTIVE-SYSTEM,EXPRESSION,OCTREOTIDE,COMBINATION,RECEPTORS,ALPHA,CELLS}},
language = {{eng}},
number = {{1}},
pages = {{59--62}},
title = {{The potential role of targeted therapies in the management of neuroendocrine tumours}},
volume = {{72}},
year = {{2009}},
}